Yüklüyor......
Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors
OBJECTIVES: Inhibition of either vascular endothelial growth factor receptor (VEGFR) or mammalian target of rapamycin (mTOR) signaling improves outcomes in patients with several advanced solid tumors. We conducted a phase I trial of temsirolimus with pazopanib to investigate the feasibility of simul...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4153755/ https://ncbi.nlm.nih.gov/pubmed/23698253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e3283618b7b |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|